NAPROXEN
- Product NDC
- 67296-1609
- 11-digit product format
- 672961609
- Labeler code
- 67296
- Product ID
- 67296-1609_d61c347b-4221-e018-e053-2995a90a4f4f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- NAPROXEN
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA091416
- Marketing category
- ANDA
- Marketing start
- 2018-01-01
- Marketing end
- 0000-00-00
- Substance
- NAPROXEN
- Active strength
- 500 mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Cyclooxygenase Inhibitors [MoA], Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1609-1 | NAPROXEN | 14 in 1 BOTTLE | TABLET | 14 | | 12 |
| 67296-1609-3 | NAPROXEN | 30 in 1 BOTTLE | TABLET | 30 | | 12 |
| 67296-1609-6 | NAPROXEN | 60 in 1 BOTTLE | TABLET | 60 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1609 | NAPROXEN TABLET [REDPHARM DRUG, INC.] | 12 | Legacy NDC, 3 package rows | 20240816_7b214238-de65-2f02-e053-2a91aa0a16db.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1609-1 | 67296160901 | 14 TABLET in 1 BOTTLE (67296-1609-1) | 14 tablet | 2018-01-01 | 0000-00-00 | No | No | Current |
| 67296-1609-3 | 67296160903 | 30 TABLET in 1 BOTTLE (67296-1609-3) | 30 tablet | 2018-01-01 | 0000-00-00 | No | No | Current |
| 67296-1609-6 | 67296160906 | 60 TABLET in 1 BOTTLE (67296-1609-6) | 60 tablet | 2018-01-01 | 0000-00-00 | No | No | Current |